Pharmaron Beijing Co., Ltd.
300759
Rank in Stocks
#2354
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Share Price
$5.58
Market Cap
$8.24B
Change (1 day)
-3.77%
Change (1 year)
28.36%
Country
CN
Trade Pharmaron Beijing Co., Ltd. (300759)
Category
Healthcare
Number of shares outstanding for Pharmaron Beijing Co., Ltd. (300759)
Number of shares outstanding as of June 2026: 1.84B
According to Pharmaron Beijing Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 1.84B. At the end of December 2024 the company had 1.77B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Pharmaron Beijing Co., Ltd. (300759) from 2014 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 1.84B | 4.27% |
| 2025 | 1.76B | -0.44% |
| 2024 | 1.77B | -0.31% |
| 2023 | 1.78B | 0.12% |
| 2022 | 1.77B | 124.21% |
| 2021 | 790.81M | 0.07% |
| 2020 | 790.22M | 20.39% |
| 2019 | 656.41M | 7.15% |
| 2018 | 612.62M | -31.00% |
| 2017 | 887.91M | 17.11% |
| 2016 | 758.19M | 50.00% |
| 2015 | 505.46M | 0.00% |
| 2014 | 505.46M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -86.18% |
US
|
|
| 396.00M | -78.45% |
US
|
|
| 478.91M | -73.93% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -96.62% |
NL
|
